Sylvie Miot
Papers
1
Total Citations
13
H-Index
1
About
Dr. Sylvie Miot is a leading figure in the translational development of Advanced Therapy Medicinal Products (ATMPs), with a particular focus on tissue-engineered cartilage for regenerative medicine. Her most cited work, "From Single Batch to Mass Production–Automated Platform Design Concept for a Phase II Clinical Trial Tissue Engineered Cartilage Product" (13 citations), addresses one of the field’s most critical bottlenecks: the scalable, automated manufacturing of cell-based therapies. Dr. Miot’s major contribution lies in bridging the gap between laboratory-scale production and clinical-grade manufacturing, designing platform concepts that ensure reproducibility, quality control, and regulatory compliance for Phase II trials. Her research directly tackles the challenge of moving promising tissue-engineered products from the bench to the bedside, particularly for unmet clinical needs in progressive and chronic diseases where no satisfying treatments exist. By pioneering automated bioprocessing strategies, Dr. Miot has helped lay the groundwork for the commercial viability of ATMPs, making her work essential reading for researchers and students in bioprocess engineering, regenerative medicine, and pharmaceutical manufacturing. Her efforts are pivotal in transforming tissue engineering from a promising concept into a tangible therapeutic reality.
Research Focus
Key Achievements
Top Papers
- 1